Phase III randomized trial of post radiation chemotherapy in patients with newly diagnosed Ependymoma ages 1 to 21 years.
Clinical Trial Information
Trial Contact: Boettger, Sadie; El-Shami, Jessica; Francois, Laetitia Claire; Spinelli, Jennifer
IRB No: ACNS0831
Protocol Abbrev: ACNS0831
Principal Investigator: Vincent F. Giusti, MD
Sub Investigators: AguilarBonilla, Ana MD; Eslin, Don MD; Martin, Rebecca, ARNP; Pope, Michele ARNP; Smith, Amy MD; Story, Allison ARNP; Sullivan Darden, Kelly ARNP; Sutphin, Robert MD; Wieber, Laura ARNP; Levy, Alejandro MD
Phase: Drug: Phase III
Age Group: Pediatric
Secondary Protocol No: ACNS0831
Treatment: Drug Therapy, Radiation, Correlative Biology Study
Therapies Involved: Chemotherapy
ClinicalTrials.gov ID: NCT01096368
A trial is studying chemotherapy to see how well it works compared to observation chemotherapy and radiation therapy in treating young patients with ependymoma.
Ages Eligible for Study: 1 Year to 21 Years; Genders Eligible for Study: Both; Accepts Healthy Volunteers: No